Document Detail

Review of clinical data with Paccocath- Coated Balloon Catheters.
MedLine Citation:
PMID:  21983304     Owner:  NLM     Status:  In-Data-Review    
The use of drug-coated balloons (DCB) for preventing restenosis in both coronary and peripheral arteries has received increasing attention. The first successful clinical outcomes in inhibiting restenosis have been reported for paclitaxel-coated balloons. Paclitaxel is a lipophilic substance characterized by rapid intracellular uptake and irreversible binding to microtubules. In this way, paclitaxel alters the cell structure, ultimately reducing proliferation, migration, and signaling. These properties make paclitaxel a very potent antiproliferative drug. Paclitaxel admixed to a small amount of the hydrophilic X-ray contrast medium iopromide (Ultravist™) emerged as a very effective coating matrix from numerous in vitro and in vivo experiments and has been denoted as Paccocath™. The randomized controlled ISR I/II-, Thunder- and FEMPAC studies have been conducted using Paccocath™ balloons. Late lumen loss as the primary endpoint at 6 months proved to be statistically significantly reduced in the coated balloon groups in coronary and peripheral arteries. The slightly modified coating on the SeQuent™ Please balloons (B.Braun, Melsungen, Germany) has been clinically studied in the PEPCAD (Paclitaxel-Eluting PTCA-Catheter in Coronary Artery Disease) clinical trial program. Cotavance™ balloons (MEDRAD Inc, Minneapolis, USA) are also coated with the Paccocath™ formulation. In this review we first outline the development of Paccocath™ balloons to then provide an overview of the clinical results obtained with the modified coating. Furthermore we examine possible mechanism of action by which single administration of an antiproliferative drug dose using paclitaxel-coated balloons inhibits restenosis.
B Schnorr; U Speck; B Scheller
Related Documents :
19843724 - In vivo imaging of the aneurysm wall with mri and a macrophage-specific contrast agent.
16971614 - Can neck size in elastase-induced aneurysms be controlled? a retrospective study.
16230794 - Three-dimensional digital subtraction angiography vs two-dimensional digital subtractio...
8165494 - Growth of small saccular aneurysms to giant aneurysms: presentation of three cases.
509844 - Radionuclide pulmonary arteriography.
17855204 - Detection of coronary arteries and evaluation of anastomoses with a commercially availa...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Minerva cardioangiologica     Volume:  59     ISSN:  0026-4725     ISO Abbreviation:  Minerva Cardioangiol     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400725     Medline TA:  Minerva Cardioangiol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  431-45     Citation Subset:  IM    
Department of Radiology, Experimental Radiology, Charité, University Hospital, Berlin, Germany -
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Update on transcatheter aortic valve implantation registries and studies.
Next Document:  Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new breakthrough in interventional...